Acino

📍 Zurich, Switzerland🗓 Founded 1836👥 1,712 employees💰 Last funded Jul 2022
Pharmaceutical Manufacturing🌐 acino.swiss
Website LinkedIn
Acino is a Swiss pharmaceutical company headquartered in Zurich, with a clear focus on selected markets in the Middle East, Africa, the CIS Region, Russia and Latin America. We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing. For more information: www.acino.swiss *** By engaging with Acino on LinkedIn (or any other Acino social media channel), you are agreeing to our Social Media Community Guidelines. If you do not agree to them, do not engage with Acino on social media. Please read our detailed community guidelines carefully here: https://acino.swiss/acino_social_media_community_guidelines_may2022 ***
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1836
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Denmark
1
United States
1
Frequently asked questions
Who invested in Acino?
Acino has 2 investors on record on gritt.io.
When did Acino last raise funding?
The most recent investment in Acino recorded on gritt.io was in July 2022.
When was Acino founded?
Acino was founded in 1836.
What industry is Acino in?
Acino operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Acino based?
Acino is headquartered in Zurich, Switzerland.